BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38184121)

  • 21. Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect.
    Shi Y; Zhang Y; Ran F; Liu J; Lin J; Hao X; Ding L; Ye Q
    Cancer Lett; 2020 Dec; 495():53-65. PubMed ID: 32946964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells.
    Zancan P; Sola-Penna M; Furtado CM; Da Silva D
    Mol Genet Metab; 2010 Aug; 100(4):372-8. PubMed ID: 20483646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer cell metabolism: implications for therapeutic targets.
    Jang M; Kim SS; Lee J
    Exp Mol Med; 2013 Oct; 45(10):e45. PubMed ID: 24091747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oleanolic Acid Inhibits High Salt-Induced Exaggeration of Warburg-like Metabolism in Breast Cancer Cells.
    Amara S; Zheng M; Tiriveedhi V
    Cell Biochem Biophys; 2016 Sep; 74(3):427-34. PubMed ID: 27236294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment.
    Xintaropoulou C; Ward C; Wise A; Queckborner S; Turnbull A; Michie CO; Williams ARW; Rye T; Gourley C; Langdon SP
    BMC Cancer; 2018 Jun; 18(1):636. PubMed ID: 29866066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of culture conditions, culture media volumes, and glucose content on metabolic properties of renal epithelial cell cultures. Are renal cells in tissue culture hypoxic?
    Gstraunthaler G; Seppi T; Pfaller W
    Cell Physiol Biochem; 1999; 9(3):150-72. PubMed ID: 10494029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exogenous normal mammary epithelial mitochondria suppress glycolytic metabolism and glucose uptake of human breast cancer cells.
    Jiang XP; Elliott RL; Head JF
    Breast Cancer Res Treat; 2015 Oct; 153(3):519-29. PubMed ID: 26407856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy.
    Abdel-Wahab AF; Mahmoud W; Al-Harizy RM
    Pharmacol Res; 2019 Dec; 150():104511. PubMed ID: 31678210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the monocarboxylate transporter MCT2 and lactate dehydrogenase A LDHA in cancer cells with FX-11 and AR-C155858 inhibitors.
    Alobaidi B; Hashimi SM; Alqosaibi AI; AlQurashi N; Alhazmi S
    Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6605-6617. PubMed ID: 37522672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose Addiction in Cancer Therapy: Advances and Drawbacks.
    Granja S; Pinheiro C; Reis RM; Martinho O; Baltazar F
    Curr Drug Metab; 2015; 16(3):221-42. PubMed ID: 26504932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-dependent metabolic dysregulation in cancer and Alzheimer's disease.
    Harris RA; Tindale L; Cumming RC
    Biogerontology; 2014 Dec; 15(6):559-77. PubMed ID: 25305052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural compounds regulate glycolysis in hypoxic tumor microenvironment.
    Gao JL; Chen YG
    Biomed Res Int; 2015; 2015():354143. PubMed ID: 25685782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MORC2 and MAX contributes to the expression of glycolytic enzymes, breast cancer cell proliferation and migration.
    Guddeti RK; Pacharla H; Yellapu NK; Karyala P; Pakala SB
    Med Oncol; 2023 Feb; 40(3):102. PubMed ID: 36802305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baicalein resensitizes tamoxifen-resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia-inducible factor-1α.
    Chen Y; Zhang J; Zhang M; Song Y; Zhang Y; Fan S; Ren S; Fu L; Zhang N; Hui H; Shen X
    Clin Transl Med; 2021 Nov; 11(11):e577. PubMed ID: 34841716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitor titrations reveal low control of glyceraldehyde 3-phosphate dehydrogenase and high control of hexokinase on glycolytic flux in an aggressive triple-negative breast cancer cell line.
    Kouril T; October C; Hollocks S; Odendaal C; van Niekerk DD; Snoep JL
    Biosystems; 2023 Sep; 231():104969. PubMed ID: 37423593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular glucose and binding of hexokinase and phosphofructokinase to particulate fractions increase under hypoxia in heart of the amazonian armored catfish (Liposarcus pardalis).
    Treberg JR; MacCormack TJ; Lewis JM; Almeida-Val VM; Val AL; Driedzic WR
    Physiol Biochem Zool; 2007; 80(5):542-50. PubMed ID: 17717817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer.
    Tilekar K; Upadhyay N; Iancu CV; Pokrovsky V; Choe JY; Ramaa CS
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188457. PubMed ID: 33096154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clotrimazole preferentially inhibits human breast cancer cell proliferation, viability and glycolysis.
    Furtado CM; Marcondes MC; Sola-Penna M; de Souza ML; Zancan P
    PLoS One; 2012; 7(2):e30462. PubMed ID: 22347377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycolytic enzyme upregulation and numbness of mitochondrial activity characterize the early phase of apoptosis in cerebellar granule cells.
    Bobba A; Amadoro G; La Piana G; Calissano P; Atlante A
    Apoptosis; 2015 Jan; 20(1):10-28. PubMed ID: 25351440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
    Vaupel P; Schmidberger H; Mayer A
    Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.